Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatid… Read more
Vivani Medical Inc. - Asset Resilience Ratio
Vivani Medical Inc. (VANI) has an Asset Resilience Ratio of 49.91% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2017)
This chart shows how Vivani Medical Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Vivani Medical Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $7.24 Million | 49.91% |
| Total Liquid Assets | $7.24 Million | 49.91% |
Asset Resilience Insights
- Very High Liquidity: Vivani Medical Inc. maintains exceptional liquid asset reserves at 49.91% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Vivani Medical Inc. Industry Peers by Asset Resilience Ratio
Compare Vivani Medical Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Vivani Medical Inc. (2012–2017)
The table below shows the annual Asset Resilience Ratio data for Vivani Medical Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 49.91% | $7.24 Million | $14.50 Million | -11.57pp |
| 2016-12-31 | 61.48% | $10.34 Million | $16.81 Million | +5.83pp |
| 2015-12-31 | 55.65% | $15.72 Million | $28.25 Million | -23.29pp |
| 2014-12-31 | 78.94% | $34.00 Million | $43.07 Million | +10.99pp |
| 2013-12-31 | 67.95% | $8.61 Million | $12.67 Million | +14.02pp |
| 2012-12-31 | 53.93% | $4.31 Million | $7.99 Million | -- |